Book

Description

The synthetic anti-diabetic drugs have side effect, associated with, and high costs, limiting their accessibility, particularly in resource-constrained settings. The rising global burden of diabetes necessitates innovative approaches to identify safe, effective, and affordable treatments. In silico drug discovery provides a powerful platform to screen natural compounds against diabetes-related protein targets, significantly reducing the time and cost associated with traditional drug development. This research bridges the gap between traditional phytotherapy and modern computational drug design.